Results

eNauka >  Rezultati >  The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Naziv: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Autori Jardine, Meg J.; Mahaffey, Kenneth W.; ...; CREDENCE study investigators; ...; Lalić, Katarina  ; Lalić, Nebojša ; ...
Godina: 2017
Publikacija: American Journal of Nephrology
ISSN: 0250-8095 American Journal of Nephrology Pretraži identifikator
Izdavač: Basel ; New York : Karger
Tip rezultata: Naučni članak
Kolacija: vol. 46 br. 6 str. 462-472
DOI: 10.1159/000484633
WoS-ID: 000418899500005
Scopus-ID: 2-s2.0-85038113623
PMID: 29253846
PMCID: PMC5804835
URI: https://enauka.gov.rs/handle/123456789/867007
URL: https://karger.com/ajn/article/46/6/462/41508/The-Canagliflozin-and-Renal-Endpoints-in-Diabetes
Izvor metapodataka: (Preuzeto iz CrossRef-a) Lalić, Katarina
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

215
SCOPUSTM
96
PubMed CentralTM
181
OpenCitations
201
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.